Integra LifeSciences Q3 Profit Tops Estimates; Revenues Down 1.5% On Organic Basis

(RTTNews) - Integra LifeSciences Holdings Corp. (IART) reported third quarter adjusted earnings per share of $0.80, compared to $0.68, last year. On average, 13 analysts polled by Thomson Reuters expected the company to report profit per share of $0.53, for the quarter. Analysts' estimates typically exclude special items.

Third quarter reported revenues were $370.2 million, a decrease of 2.3% on a reported basis and a decrease of 1.5% on an organic basis compared to the prior year. Analysts expected revenue of $347.98 million, for the quarter.

Due to the ongoing uncertainty related to the pandemic, the company's guidance for the full-year 2020 remains withdrawn.

"Better than expected performance in the third quarter was driven by stronger recovery trends and solid execution across the organization. Barring significant worsening of the pandemic, we believe these efforts will result in a further sequential revenue improvement in the fourth quarter," said Peter Arduini, Integra's CEO.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More